Although we found no evidence that atypical BRAF mutations are associated with the MSI or POLE mutator phenotypes, it remained possible that their occurrence was driven by other mutational processes that are active in tumor cells or their precursors, mostly in the distal colorectum. This evidence concerns the gene BRAF and neoplasm.